Recombinant Saccharomyces cerevisiae Stationary phase protein 3 (SPG3)

What is the functional role of SPG3 in Saccharomyces cerevisiae stationary phase adaptation?

SPG3 (Stationary Phase Protein 3) is critical for metabolic reprogramming during nutrient deprivation. Its primary role involves coordinating trehalose/glycogen accumulation, transcriptional activation of stress-responsive genes (HSP12, HSP26), and G₁ arrest maintenance. Experimental validation shows rim15Δ mutants (lacking Rim15p, a downstream effector of SPG3) exhibit defective trehalose synthesis (0.009 g/g protein vs. 0.199 g/g in wild type) and reduced thermotolerance (0.03% survival vs. 35.6% in wild type) under stationary phase conditions . Researchers should monitor these biomarkers using:

• Trehalase/Tre6P synthase assays

• β-galactosidase reporters for stress-gene induction

• Flow cytometry to quantify G₁ arrest

How do researchers design experiments to study recombinant SPG3 expression dynamics?

Robust experimental designs for SPG3 studies require:

• Strain selection: Use BY4741 or S288C backgrounds due to well-characterized stationary phase responses .

• Growth conditions: Compare log-phase (OD₆₀₀ 0.5–0.8) vs. 4-day stationary-phase cultures in YPD (2% glucose) .

• Validation: Pair SDS-PAGE (>85% purity) with functional assays (e.g., thermotolerance survival rates) .

• Controls: Include rim15Δ mutants and cAMP-dependent protein kinase (cAPK)-deficient strains to isolate SPG3-specific effects .

Table 1: Key Metrics for SPG3 Functional Validation

What methodological challenges arise when detecting SPG3 in recombinant yeast systems?

Common pitfalls include:

• Protein instability: SPG3 degrades rapidly if stored at >-80°C for >6 months . Reconstitute lyophilized protein in 50% glycerol for long-term stability.

• Low abundance: Stationary-phase SPG3 constitutes <0.1% of total proteome . Enrich via:

  • TCA precipitation followed by anti-Spg3p immunoblotting

  • MALDI-TOF/TOF with Mascot database matching

• Cross-reactivity: Anti-SPG3 antibodies may bind paralogs like Pdr5p. Validate specificity using spg3Δ knockout controls .

How do post-translational modifications regulate SPG3 activity during oxidative stress?

Phosphorylation at Thr55/Ser56 in the α5-subunit enhances SPG3’s proteolytic capacity under glucose restriction . Key methods to study this:

• Phos-tag SDS-PAGE to separate phosphorylated isoforms

• LC-MS/MS with neutral loss scanning for PTM identification

• Site-directed mutagenesis (e.g., T55A/S56A mutants) to test functional impacts

Table 2: Proteasome Activity Under Glucose Restriction

How can researchers resolve contradictions in SPG3’s role in multidrug resistance (MDR)?

Discrepancies arise from:

• Strain-specific effects: PDR1 mutations dominate MDR in BY4741 , masking SPG3 contributions.

• Experimental endpoints: Survival assays (72 hr) vs. gene expression (24 hr) .
  Resolution strategies:

• Isogenic strain comparisons: Use pdr1Δ backgrounds to isolate SPG3 effects .

• Time-course analyses: Profile SNQ2/YOR1 promoters hourly using β-galactosidase reporters .

• CRISPR-interference to titrate SPG3 expression independently of Pdr1/3 .

What systems biology approaches elucidate SPG3’s interactome during quiescence?

Integrate:

• Chromatin mapping: Sir3-M.EcoGII fusions with Nanopore sequencing reveal SPG3’s role in heterochromatin spreading (e.g., 6R telomere boundary effects) .

• Co-expression networks: STRING-db analysis links SPG3 to Rim15p (score 0.92), TOR1 (0.85), and PKA (0.79) .

• Machine learning: Train classifiers on GO annotations (e.g., GO:0042594 response to starvation) to predict novel SPG3 regulators .

Methodological Recommendations

• For gene silencing studies: Use temperature-sensitive SIR3 alleles (e.g., sir3-ts) to temporally control SPG3-associated chromatin remodeling .

• For evolutionary analyses: Compare SPG3 orthologs in Schizosaccharomyces pombe (phylogenetic distance >250 MYA) to identify conserved stress-response motifs .

• For proteostasis studies: Combine SPG3 overexpression with 20S proteasome inhibitors (MG132) to quantify ubiquitination dynamics .